Phosphorylation of argininosuccinate synthase by protein kinase A

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1042-1046

  Corbin, Karen D ^a   Pendleton, Laura C ^a   Solomonson, Larry P ^a   Eichler, Duane C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Argininosuccinate synthase; Nitric oxide; Phosphorylation; Protein kinase A; Vascular endothelial growth factor; Vascular endothelium

Indexed keywords

ARGININOSUCCINATE SYNTHASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; VASCULOTROPIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ARGININOSUCCINATE SYNTHASE; CATTLE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; NITRIC OXIDE; PHOSPHORYLATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56349133959     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.056     Document Type: Article

References (35)

1. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63 (1994) 175-195
2. Vallance P., and Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 85 (2001) 342-350
3. Husson A., Brasse-Lagnel C., Fairand A., Renouf S., and Lavoinne A. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur. J. Biochem. 270 (2003) 1887-1899
4. Xie L., Hattori Y., Tume N., and Gross S.S. The preferred source of arginine for high-output nitric oxide synthesis in blood vessels. Semin. Perinatol. 24 (2000) 42-45
5. Boo Y.C., Hwang J., Sykes M., Michell B.J., Kemp B.E., Lum H., and Jo H. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1819-1828
6. Cho D.H., Choi Y.J., Jo S.A., and Jo I. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways. J. Biol. Chem. 279 (2004) 2499-2506
7. Feliers D., Chen X., Akis N., Choudhury G.G., Madaio M., and Kasinath B.S. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int. 68 (2005) 1648-1659
8. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
9. Harris M.B., Ju H., Venema V.J., Liang H., Zou R., Michell B.J., Chen Z.P., Kemp B.E., and Venema R.C. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J. Biol. Chem. 276 (2001) 16587-16591
10. Morrow V.A., Foufelle F., Connell J.M., Petrie J.R., Gould G.W., and Salt I.P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J. Biol. Chem. 278 (2003) 31629-31639
11. Reihill J.A., Ewart M.A., Hardie D.G., and Salt I.P. AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem. Biophys. Res. Commun. 354 (2007) 1084-1088
12. Bauer P.M., Fulton D., Boo Y.C., Sorescu G.P., Kemp B.E., Jo H., and Sessa W.C. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J. Biol. Chem. 278 (2003) 14841-14849
13. Brouet A., Sonveaux P., Dessy C., Balligand J.L., and Feron O. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J. Biol. Chem. 276 (2001) 32663-32669
14. Gonzalez E., Kou R., Lin A.J., Golan D.E., and Michel T. Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J. Biol. Chem. 277 (2002) 39554-39560
15. Gratton J.P., Fontana J., O'Connor D.S., Garcia-Cardena G., McCabe T.J., and Sessa W.C. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J. Biol. Chem. 275 (2000) 22268-22272
16. Hood J.D., Meininger C.J., Ziche M., and Granger H.J. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am. J. Physiol. 274 (1998) H1054-1058
17. Takahashi S., and Mendelsohn M.E. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J. Biol. Chem. 278 (2003) 30821-30827
18. Xie L., and Gross S.S. Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO production. J. Biol. Chem. 272 (1997) 16624-16630
19. Flam B.R., Eichler D.C., and Solomonson L.P. Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide 17 (2007) 115-121
20. Li C., Huang W., Harris M.B., Goolsby J.M., and Venema R.C. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport. Biochem. J. 386 (2005) 567-574
21. Shen L.J., Beloussow K., and Shen W.C. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem. Pharmacol. 69 (2005) 97-104
22. Goodwin B.L., Pendleton L.C., Levy M.M., Solomonson L.P., and Eichler D.C. Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H1115-H1121
23. Anderson H.D., Rahmutula D., and Gardner D.G. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J. Biol. Chem. 279 (2004) 963-969
24. Goodwin B.L., Corbin K.D., Pendleton L.C., Levy M.M., Solomonson L.P., and Eichler D.C. Troglitazone up-regulates vascular endothelial argininosuccinate synthase. Biochem. Biophys. Res. Commun. 370 (2008) 254-258
25. McCormick S.M., Eskin S.G., McIntire L.V., Teng C.L., Lu C.M., Russell C.G., and Chittur K.K. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. USA 98 (2001) 8955-8960
26. Goodwin B.L., Solomonson L.P., and Eichler D.C. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J. Biol. Chem. 279 (2004) 18353-18360
27. Gimbrone Jr. M.A. Culture of vascular endothelium. Prog. Hemost. Thromb. 3 (1976) 1-28
28. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., and Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214 (1993) 11-16
29. Ratner S. Enzymes of arginine and urea synthesis. Adv. Enzymol. Relat. Areas Mol. Biol. 39 (1973) 1-90
30. Hao G., Xie L., and Gross S.S. Argininosuccinate synthetase is reversibly inactivated by S-nitrosylation in vitro and in vivo. J. Biol. Chem. 279 (2004) 36192-36200
31. Imami K., Sugiyama N., Kyono Y., Tomita M., and Ishihama Y. Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal. Sci. 24 (2008) 161-166
32. Kliche S., and Waltenberger J. VEGF receptor signaling and endothelial function. IUBMB Life 52 (2001) 61-66
33. Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler B., Kearney M., Couffinhal T., and Isner J.M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat. Med. 3 (1997) 879-886
34. Uhlmann S., Friedrichs U., Eichler W., Hoffmann S., and Wiedemann P. Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells. Microvasc. Res. 62 (2001) 179-189
35. Jesmin S., Zaedi S., Shimojo N., Iemitsu M., Masuzawa K., Yamaguchi N., Mowa C.N., Maeda S., Hattori Y., and Miyauchi T. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1030-E1040